PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
基本信息
- 批准号:3457923
- 负责人:
- 金额:$ 4.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-05-01 至 1992-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The leukemic cell is characterized by maturational arrest at a
stage of hematopoietic development where the ability to
proliferate is maintained. Human leukenic cells cultured in vitro
can be stimulated to develop into a non-proliferating cell. Thus,
the leukemias can be viewed, in part, as a disorder of
differentiation as well as proliferation. One of the most potent
agents stimulating differentiation of leukemic cells is
120tetradecanoyl phorbol 13-acetate (TPA), a phorbol ester. By
substituting for diacylglycerol, TPA activates the CA2+-
phospholipiddependent kinase, protein kinase C. The ability of
diacyglycerol derivatives to mimic TPA stimulated cellular
responses indicates that protein kinase C activation may mediate
a portion of the cellular effects exerted by TPA. However,
diacylglycerol derivatives are unable to stimulate differentiation
of the human leukemic cell line U937. In our laboratory, a non-
protein kinase C, TPA stimulated kinase activity has been
identified. Protein kinase C and the TPA stimulated kinase
activity can be distinguished by differences in substrate
specificity. The inability of diacylglycerol derivatives to
stimulate differentiation or to activate this kinase suggests that
activation of the TPA stimulated kinase may be important in
mediating TPA stimulated differentiation.
The goal of this proposal is to characterize the nonprotein kinase
C, TPA stimulated kinase and to determine if activation of this
kinase is crucial in mediating the signal stimulating
differentiation of the leukemic cell. Using column
chromatography, this kinase will be characterized and compared
to other non-protein kinase C phosphotransferase activities
stimulated by TPA. Using 32P-labeled intact cells and two
dimensional electrophoretic analysis, endogenous substrates
phosphorylated by this kinase will be defined. The effects of
other agents inducing U937 differentiation (lymphokines, dibutryl
cAMP, etc.) will be evaluated for effects on this kinase activity.
A better understanding of the mechanism controlling
differentiation of human leukemic cells would aid in developing
therapeutic modalities specifically designed to stimulate the in
vivo differentiation of leukemic cells. Such a therapy, in addition
to providing an alternative form of treatment, would theoretically
avoid many of the toxic side effects inherent to the currently
used antineoplastic therapy. The proposed research could also
provide insight into the mechanisms mediating the many diverse
effects exerted by phorbol esters in other biological systems.
白血病细胞的特征是成熟时停滞。
在造血发育阶段,有能力
增殖维持不变。体外培养的人白血病细胞
可以被刺激发育成非增殖细胞。因此,
白血病可以部分地被视为一种疾病。
分化与增殖一样重要。最强大的力量之一
刺激白血病细胞分化的药物是
120十四酰佛波醇13-乙酸酯(TPA),佛波醇酯。通过
取代甘油二酯,TPA激活钙离子。
磷脂依赖激酶,蛋白激酶C。
二甘油衍生物模拟TPA刺激的细胞
反应表明,蛋白激酶C的激活可能介导了
TPA所产生的细胞效应的一部分。然而,
甘油二酯衍生物不能刺激分化
人类白血病细胞系U937。在我们的实验室里,一种非
蛋白激酶C、TPA刺激的激酶活性已被
确认身份。蛋白激酶C与TPA刺激的蛋白激酶
活性可以通过底物的不同来区分
专一性。二酰基甘油衍生物不能
刺激分化或激活这一激酶表明
TPA刺激的激酶的激活可能在
中介TPA可促进细胞分化。
这项提议的目标是表征非蛋白激酶
C,TPA刺激的激酶,并确定这一激活
激酶在介导信号刺激中起着至关重要的作用
白血病细胞的分化。使用列
层析后,将对该激酶进行表征和比较
对其他非蛋白激酶C磷酸转移酶活性的影响
受TPA刺激。使用32P标记的完整细胞和两个
内源性底物的空间电泳法
由该激酶磷酸化将被定义。的影响
其他诱导U937分化的药物(淋巴因子、二丁三醇
营房等)将被评估对该激酶活性的影响。
更好地理解控制机制
人类白血病细胞的分化将有助于发育
专门设计的治疗方式,旨在刺激
白血病细胞的体内分化。这样的一种疗法,另外
提供另一种治疗形式,从理论上讲
避免许多毒副作用,这是目前
使用了抗肿瘤治疗。拟议中的研究还可以
提供对调解许多不同的
佛波醇酯在其他生物系统中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS K. WAYS其他文献
DOUGLAS K. WAYS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS K. WAYS', 18)}}的其他基金
PHORBOL ESTER-INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3186193 - 财政年份:1994
- 资助金额:
$ 4.08万 - 项目类别:
CHARACTERIZATION OF PROTEIN KINASE C GENE RESPONSE ELEME
蛋白激酶 C 基因反应元件的表征
- 批准号:
3023319 - 财政年份:1991
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER-INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3186194 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3457925 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER-INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3186192 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3447011 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3457922 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3457926 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
PHORBOL ESTER INDUCED DIFFERENTIATION OF LEUKEMIC CELLS
佛波酯诱导白血病细胞分化
- 批准号:
3457924 - 财政年份:1987
- 资助金额:
$ 4.08万 - 项目类别:
相似海外基金
High-resolution liquid chromatography mass spectrometry system
高分辨率液相色谱质谱系统
- 批准号:
524805621 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Major Research Instrumentation
Thermogravimetric Analysis Combined with Calorimetry and Gas-Chromatography/Mass Spectrometry
热重分析与量热法和气相色谱/质谱联用
- 批准号:
530331787 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Major Research Instrumentation
Ultra High-Performance Liquid Chromatography High-Resolution Mass Spectrometer (UHPLC-HRMS)
超高性能液相色谱高分辨率质谱仪 (UHPLC-HRMS)
- 批准号:
529714284 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Major Research Instrumentation
High-resolution mass spectrometer with Liquid Chromatography (LC) and Capillary Electrophoresis (CE)
具有液相色谱 (LC) 和毛细管电泳 (CE) 功能的高分辨率质谱仪
- 批准号:
515835726 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Major Research Instrumentation
Pore Engineering of Chromatography Membranes for Bioseparation
生物分离色谱膜的孔隙工程
- 批准号:
LP210301317 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Linkage Projects
MRI: Track 1 Acquisition of a Liquid Chromatography-Electrospray Ionization-Quadrupole Time of Flight Mass Spectrometer for Central Michigan University
MRI:轨道 1 为中密歇根大学采购液相色谱-电喷雾电离-四极杆飞行时间质谱仪
- 批准号:
2320737 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Standard Grant
Capacity: FSML: Acquisition of an Isotope Ratio Mass Spectrometer with liquid chromatography and elemental analyzer interfaces at the Skidaway Institute of Oceanography
能力:FSML:在斯基德威海洋研究所购买一台带液相色谱和元素分析仪接口的同位素比质谱仪
- 批准号:
2312015 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Standard Grant
Automated data processing for two dimensional gas chromatography based metabolomics
基于二维气相色谱的代谢组学的自动数据处理
- 批准号:
495564 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Miscellaneous Programs
Exclusion chromatography system coupled to detectors
与检测器耦合的排阻色谱系统
- 批准号:
529276114 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Major Research Instrumentation
Establishment of comprehensive analysis of isomeric and similar compounds using liquid chromatography-mass spectrometry
异构及相似化合物液相色谱-质谱综合分析方法的建立
- 批准号:
23K09776 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)